A citation-based method for searching scientific literature

Gabriel S Macedo, Barbara Alemar, Patricia Ashton-Prolla. Genet Mol Biol 2019
Times Cited: 8







List of co-cited articles
4 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers.
Karoline B Kuchenbaecker, John L Hopper, Daniel R Barnes, Kelly-Anne Phillips, Thea M Mooij, Marie-José Roos-Blom, Sarah Jervis, Flora E van Leeuwen, Roger L Milne, Nadine Andrieu,[...]. JAMA 2017
867
37

A systematic review of the international prevalence of BRCA mutation in breast cancer.
Nigel Armstrong, Steve Ryder, Carol Forbes, Janine Ross, Ruben Gw Quek. Clin Epidemiol 2019
56
25

Identification of the breast cancer susceptibility gene BRCA2.
R Wooster, G Bignell, J Lancaster, S Swift, S Seal, J Mangion, N Collins, S Gregory, C Gumbs, G Micklem. Nature 1995
25

A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1.
Y Miki, J Swensen, D Shattuck-Eidens, P A Futreal, K Harshman, S Tavtigian, Q Liu, C Cochran, L M Bennett, W Ding. Science 1994
25

Paraneoplastic pemphigus in children and adolescents.
D Mimouni, G J Anhalt, Z Lazarova, S Aho, S Kazerounian, D J Kouba, J M Mascaro, H C Nousari. Br J Dermatol 2002
94
12

In brief: BRCA1 and BRCA2.
William D Foulkes, Andrew Y Shuen. J Pathol 2013
56
12

An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients.
Balazs Györffy, Andras Lanczky, Aron C Eklund, Carsten Denkert, Jan Budczies, Qiyuan Li, Zoltan Szallasi. Breast Cancer Res Treat 2010
12

Germline breast cancer susceptibility gene mutations and breast cancer outcomes.
Yong Alison Wang, Jhih-Wei Jian, Chen-Fang Hung, Hung-Pin Peng, Chi-Fan Yang, Hung-Chun Skye Cheng, An-Suei Yang. BMC Cancer 2018
31
12

TTK promotes mesenchymal signaling via multiple mechanisms in triple negative breast cancer.
Jamie L King, Baotong Zhang, Yixiang Li, Kathy P Li, Jianping J Ni, Harold I Saavedra, Jin-Tang Dong. Oncogenesis 2018
30
12

Cyclin E1 deregulation occurs early in secretory cell transformation to promote formation of fallopian tube-derived high-grade serous ovarian cancers.
Alison M Karst, Paul M Jones, Natalie Vena, Azra H Ligon, Joyce F Liu, Michelle S Hirsch, Dariush Etemadmoghadam, David D L Bowtell, Ronny Drapkin. Cancer Res 2014
91
12

Secondary mutations in BRCA2 associated with clinical resistance to a PARP inhibitor.
Louise J Barber, Shahneen Sandhu, Lina Chen, James Campbell, Iwanka Kozarewa, Kerry Fenwick, Ioannis Assiotis, Daniel Nava Rodrigues, Jorge S Reis Filho, Victor Moreno,[...]. J Pathol 2013
201
12

Clinical and immunological findings in 104 cases of paraneoplastic pemphigus.
A Ohzono, R Sogame, X Li, K Teye, A Tsuchisaka, S Numata, H Koga, T Kawakami, D Tsuruta, N Ishii,[...]. Br J Dermatol 2015
72
12

Cell cycle, cytoskeleton dynamics and beyond: the many functions of cyclins and CDK inhibitors.
Nawal Bendris, Bénédicte Lemmers, Jean Marie Blanchard. Cell Cycle 2015
98
12

BRCA1-BARD1 promotes RAD51-mediated homologous DNA pairing.
Weixing Zhao, Justin B Steinfeld, Fengshan Liang, Xiaoyong Chen, David G Maranon, Chu Jian Ma, Youngho Kwon, Timsi Rao, Weibin Wang, Chen Sheng,[...]. Nature 2017
136
12

The prevalence of BRCA1 mutations among young women with triple-negative breast cancer.
S R Young, Robert T Pilarski, Talia Donenberg, Charles Shapiro, Lyn S Hammond, Judith Miller, Karen A Brooks, Stephanie Cohen, Beverly Tenenholz, Damini Desai,[...]. BMC Cancer 2009
169
12

Five screening-detected breast cancer cases in initially disease-free BRCA1 or BRCA2 mutation carriers.
Satoko Shimada, Reiko Yoshida, Eri Nakashima, Dai Kitagawa, Naoya Gomi, Rie Horii, Sayoko Takeuchi, Yuumi Ashihara, Mizuho Kita, Futoshi Akiyama,[...]. Breast Cancer 2019
3
33

Clinical and pathologic characteristics of patients with BRCA-positive and BRCA-negative breast cancer.
Deann P Atchley, Constance T Albarracin, Adriana Lopez, Vicente Valero, Christopher I Amos, Ana Maria Gonzalez-Angulo, Gabriel N Hortobagyi, Banu K Arun. J Clin Oncol 2008
351
12

Discovery and validation of 3 novel DNA methylation markers of prostate cancer prognosis.
Susan Cottrell, Klaus Jung, Glen Kristiansen, Elke Eltze, Axel Semjonow, Michael Ittmann, Arndt Hartmann, Thomas Stamey, Carolina Haefliger, Gunter Weiss. J Urol 2007
58
12

The Discovery of a Dual TTK Protein Kinase/CDC2-Like Kinase (CLK2) Inhibitor for the Treatment of Triple Negative Breast Cancer Initiated from a Phenotypic Screen.
Jennifer R Riggs, Mark Nagy, Jan Elsner, Paul Erdman, Dan Cashion, Dale Robinson, Roy Harris, Dehua Huang, Lida Tehrani, Gordafaried Deyanat-Yazdi,[...]. J Med Chem 2017
25
12

Non-Coding Variants in BRCA1 and BRCA2 Genes: Potential Impact on Breast and Ovarian Cancer Predisposition.
Elizabeth Santana Dos Santos, François Lallemand, Leslie Burke, Dominique Stoppa-Lyonnet, Melissa Brown, Sandrine M Caputo, Etienne Rouleau. Cancers (Basel) 2018
8
12

A novel protease inhibitor of the alpha2-macroglobulin family expressed in the human epidermis.
Marie-Florence Galliano, Eve Toulza, Hélène Gallinaro, Nathalie Jonca, Akemi Ishida-Yamamoto, Guy Serre, Marina Guerrin. J Biol Chem 2006
57
12

High incidence of germline BRCA mutation in patients with ER low-positive/PR low-positive/HER-2 neu negative tumors.
Rachel A Sanford, Juhee Song, Angelica M Gutierrez-Barrera, Jessica Profato, Ashley Woodson, Jennifer Keating Litton, Isabelle Bedrosian, Constance T Albarracin, Vicente Valero, Banu Arun. Cancer 2015
21
12

Identification of early molecular markers for breast cancer.
Céline Kretschmer, Anja Sterner-Kock, Friederike Siedentopf, Winfried Schoenegg, Peter M Schlag, Wolfgang Kemmner. Mol Cancer 2011
126
12


The yield of full BRCA1/2 genotyping in Israeli Arab high-risk breast/ovarian cancer patients.
Rinat Bernstein-Molho, Inbal Barnes-Kedar, Mark D Ludman, Gili Reznik, Hagit Baris Feldman, Nadra Nasser Samra, Avital Eilat, Tamar Peretz, Lilach Peled Peretz, Tamar Shapira,[...]. Breast Cancer Res Treat 2019
4
25

Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal.
Jianjiong Gao, Bülent Arman Aksoy, Ugur Dogrusoz, Gideon Dresdner, Benjamin Gross, S Onur Sumer, Yichao Sun, Anders Jacobsen, Rileen Sinha, Erik Larsson,[...]. Sci Signal 2013
12

cytoHubba: identifying hub objects and sub-networks from complex interactome.
Chia-Hao Chin, Shu-Hwa Chen, Hsin-Hung Wu, Chin-Wen Ho, Ming-Tat Ko, Chung-Yen Lin. BMC Syst Biol 2014
12

CCNE1 amplification is associated with poor prognosis in patients with triple negative breast cancer.
Zi-Ming Zhao, Susan E Yost, Katherine E Hutchinson, Sierra Min Li, Yate-Ching Yuan, Javad Noorbakhsh, Zheng Liu, Charles Warden, Radia M Johnson, Xiwei Wu,[...]. BMC Cancer 2019
23
12

The Molecular Signatures Database (MSigDB) hallmark gene set collection.
Arthur Liberzon, Chet Birger, Helga Thorvaldsdóttir, Mahmoud Ghandi, Jill P Mesirov, Pablo Tamayo. Cell Syst 2015
12



MRE11 and EXO1 nucleases degrade reversed forks and elicit MUS81-dependent fork rescue in BRCA2-deficient cells.
Delphine Lemaçon, Jessica Jackson, Annabel Quinet, Joshua R Brickner, Shan Li, Stephanie Yazinski, Zhongsheng You, Grzegorz Ira, Lee Zou, Nima Mosammaparast,[...]. Nat Commun 2017
167
12

Heterozygous germline mutations in A2ML1 are associated with a disorder clinically related to Noonan syndrome.
Lisenka E L M Vissers, Monica Bonetti, Jeroen Paardekooper Overman, Willy M Nillesen, Suzanna G M Frints, Joep de Ligt, Giuseppe Zampino, Ana Justino, José C Machado, Marga Schepens,[...]. Eur J Hum Genet 2015
44
12

Genetic susceptibility to triple-negative breast cancer.
Kristen N Stevens, Celine M Vachon, Fergus J Couch. Cancer Res 2013
125
12

Critical role of neuropeptides B/W receptor 1 signaling in social behavior and fear memory.
Ruby Nagata-Kuroiwa, Naoki Furutani, Junko Hara, Mari Hondo, Makoto Ishii, Tomomi Abe, Michihiro Mieda, Natsuko Tsujino, Toshiyuki Motoike, Yuchio Yanagawa,[...]. PLoS One 2011
21
12


Significant association of the EXO1 rs851797 polymorphism with clinical outcome of ovarian cancer.
Tingyan Shi, Rong Jiang, Pan Wang, Yuan Xu, Sheng Yin, Xi Cheng, Rongyu Zang. Onco Targets Ther 2017
7
14

EXO1 overexpression is associated with poor prognosis of hepatocellular carcinoma patients.
Yaoyao Dai, Zuxiong Tang, Zongguo Yang, Lan Zhang, Qing Deng, Xiaofeng Zhang, Yongchun Yu, Xing Liu, Junfeng Zhu. Cell Cycle 2018
15
12

Breast cancer risk factors differ between Asian and white women with BRCA1/2 mutations.
Monique A de Bruin, Ava Kwong, Benjamin A Goldstein, Jafi A Lipson, Debra M Ikeda, Lisa McPherson, Bhavna Sharma, Ani Kardashian, Elizabeth Schackmann, Kerry E Kingham,[...]. Fam Cancer 2012
16
12


TRIM58/cg26157385 methylation is associated with eight prognostic genes in lung squamous cell carcinoma.
Weimin Zhang, Qichen Cui, Weifeng Qu, Xiaoyun Ding, Donglin Jiang, Hongcheng Liu. Oncol Rep 2018
23
12


Hereditary breast and ovarian cancer: assessment of point mutations and copy number variations in Brazilian patients.
Felipe C Silva, Bianca Cg Lisboa, Marcia Cp Figueiredo, Giovana T Torrezan, Erika Mm Santos, Ana C Krepischi, Benedito M Rossi, Maria I Achatz, Dirce M Carraro. BMC Med Genet 2014
39
12

Next-generation sequencing for the diagnosis of hereditary breast and ovarian cancer using genomic capture targeting multiple candidate genes.
Laurent Castéra, Sophie Krieger, Antoine Rousselin, Angélina Legros, Jean-Jacques Baumann, Olivia Bruet, Baptiste Brault, Robin Fouillet, Nicolas Goardon, Olivier Letac,[...]. Eur J Hum Genet 2014
160
12

In Silico Systems Biology Analysis of Variants of Uncertain Significance in Lynch Syndrome Supports the Prioritization of Functional Molecular Validation.
Ester Borras, Kyle Chang, Mala Pande, Amanda Cuddy, Jennifer L Bosch, Sarah A Bannon, Maureen E Mork, Miguel A Rodriguez-Bigas, Melissa W Taggart, Patrick M Lynch,[...]. Cancer Prev Res (Phila) 2017
6
16

Structure and activation mechanism of the CHK2 DNA damage checkpoint kinase.
Zhenjian Cai, Nabil H Chehab, Nikola P Pavletich. Mol Cell 2009
102
12

ABRAXAS (FAM175A) and Breast Cancer Susceptibility: No Evidence of Association in the Breast Cancer Family Registry.
Anne-Laure Renault, Fabienne Lesueur, Yan Coulombe, Stéphane Gobeil, Penny Soucy, Yosr Hamdi, Sylvie Desjardins, Florence Le Calvez-Kelm, Maxime Vallée, Catherine Voegele,[...]. PLoS One 2016
4
25

USP13 regulates the RAP80-BRCA1 complex dependent DNA damage response.
Yunhui Li, Kuntian Luo, Yujiao Yin, Chenming Wu, Min Deng, Lei Li, Yuping Chen, Somaira Nowsheen, Zhenkun Lou, Jian Yuan. Nat Commun 2017
40
12


Linkage of early-onset familial breast cancer to chromosome 17q21.
J M Hall, M K Lee, B Newman, J E Morrow, L A Anderson, B Huey, M C King. Science 1990
12


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.